Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
I-123 imaging for the predicti...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
I-123 imaging for the prediction of I-131 therapy for recurrent differentiated thyroid cancer, RDTC, when I-131 tracer is negative but raised thyroglobulin, Tg
Bibliographic Details
Main Authors:
Britton, K
,
Foley, R
,
Siddiqi, A
,
Jan, H
,
Canizales, A
,
Plowman, P
,
Grossman, AB
,
Monson, J
,
Besser, G
Format:
Journal article
Published:
1999
Holdings
Description
Similar Items
Staff View
Similar Items
The management of differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy.
by: Ali, N, et al.
Published: (2006)
The role of 123I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131I-scanning: avoidance of negative therapeutic uptake due to stunning.
by: Siddiqi, A, et al.
Published: (2001)
Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
by: Mukherjee, J, et al.
Published: (2001)
NMR-ON MEASUREMENTS OF I-123, I-124, I-131 IN NICKEL
by: Ohya, S, et al.
Published: (1992)
Prevalence of Thyroglobulin Antibody (TgAb) positivity in patients post treatment for differentiated thyroid carcinoma and verification of serum thyroglobulin measurements by thyroglobulin recovery test and TgAb assay
by: Kathiravelu, Kaameny, et al.
Published: (2022)